buprenorphine and naloxone (Gemini Laboratories, LLC)
Welcome to the PulseAid listing for the buprenorphine and naloxone drug offered from Gemini Laboratories, LLC. This Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gemini Laboratories, LLC |
| NON-PROPRIETARY NAME: | BUPRENORPHINE HYDROCHLORIDE NALOXONE HYDROCHLORIDE DIHYDRATE |
| SUBSTANCE NAME: | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | PILL |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-11-11 |
| END MARKETING DATE: | 0000-00-00 |
buprenorphine and naloxone HUMAN PRESCRIPTION DRUG Details:
| Item Description | buprenorphine and naloxone from Gemini Laboratories, LLC |
| LABELER NAME: | Gemini Laboratories, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2016-11-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60846-970_41882d70-bba9-7011-e054-00144ff88e88 |
| PRODUCT NDC: | 60846-970 |
| APPLICATION NUMBER: | ANDA203136 |
Other BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE Pharmaceutical Manufacturers / Labelers:
